- <![CDATA[Tirabrutinib and CAR T-Cell Therapy Represent Potential Paradigm Shifts in R/R PCNSL ]]><![CDATA[Ashley Sumrall, MD, FACP, FASCO, discusses emerging data for tirabrutinib and the evolving role of CAR T-cell therapy in primary central nervous system lymphoma.]]>onclive · 2mo ago↗ source
- Valneva to cut up to 15% of jobs as reduced travel hits vaccine demandFrench vaccine maker Valneva is laying off 10% to 15% of its workforce and reducing revenue projections due to "an emerging adverse trend in travel vaccine uptake across key markets." The drugmakerEndpoints · 2mo ago↗ source
- <![CDATA[Future Directions in Metastatic Castration-Resistant Prostate Cancer]]><![CDATA[Dr. Pedro Barata and Dr. Johann De Bono conclude the discussion by reflecting on the evolving future of radiopharmaceutical therapies in metastatic castration-resistant prostate cancer (mC…